CR011-vcMMAE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CR011-vcMMAE, covering 2015-02-19 to 2015-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma [Phase 1, Phase 2]